FR2374911A1 - Adjuvants d'immunite non specifique - Google Patents

Adjuvants d'immunite non specifique

Info

Publication number
FR2374911A1
FR2374911A1 FR7638566A FR7638566A FR2374911A1 FR 2374911 A1 FR2374911 A1 FR 2374911A1 FR 7638566 A FR7638566 A FR 7638566A FR 7638566 A FR7638566 A FR 7638566A FR 2374911 A1 FR2374911 A1 FR 2374911A1
Authority
FR
France
Prior art keywords
specific immunity
adjuvants
immunity adjuvants
chosen
nocardia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7638566A
Other languages
English (en)
Other versions
FR2374911B1 (fr
Inventor
Lucien Dussourd D Hinterland
Anne-Marie Pinel
Gerard Normier
Jacques Durand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7638566A priority Critical patent/FR2374911A1/fr
Priority to BE183395A priority patent/BE861782A/fr
Priority to DE19772756851 priority patent/DE2756851A1/de
Priority to GB5296177A priority patent/GB1551178A/en
Priority to ES465295A priority patent/ES465295A1/es
Publication of FR2374911A1 publication Critical patent/FR2374911A1/fr
Application granted granted Critical
Publication of FR2374911B1 publication Critical patent/FR2374911B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Abstract

La présente invention concerne des adjuvants d'immunité non spécifique. Il s'agit plus particulièrement d'adjuvants d'immunité non spécifique qui contiennent au moins une fraction choisie parmi les ribosomes et les acides ribonucléiques ribosomaux d'au moins une bactérie choisie parmi certaines souches de Corynebacterium, Mycobacterium et Nocardia. Ces adjuvants d'immunité non spécifique sont utiles pour la prévention des maladies infectieuses.
FR7638566A 1976-12-21 1976-12-21 Adjuvants d'immunite non specifique Granted FR2374911A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR7638566A FR2374911A1 (fr) 1976-12-21 1976-12-21 Adjuvants d'immunite non specifique
BE183395A BE861782A (fr) 1976-12-21 1977-12-12 Adjuvants d'immunite non specifique.
DE19772756851 DE2756851A1 (de) 1976-12-21 1977-12-20 Adjuvantien unspezifischer immunitaet
GB5296177A GB1551178A (en) 1976-12-21 1977-12-20 Nonspecific immunity adjuvants
ES465295A ES465295A1 (es) 1976-12-21 1977-12-21 Procedimiento de preparacion de adyuvantes de inmunidad no especifica.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7638566A FR2374911A1 (fr) 1976-12-21 1976-12-21 Adjuvants d'immunite non specifique

Publications (2)

Publication Number Publication Date
FR2374911A1 true FR2374911A1 (fr) 1978-07-21
FR2374911B1 FR2374911B1 (fr) 1979-04-13

Family

ID=9181350

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7638566A Granted FR2374911A1 (fr) 1976-12-21 1976-12-21 Adjuvants d'immunite non specifique

Country Status (5)

Country Link
BE (1) BE861782A (fr)
DE (1) DE2756851A1 (fr)
ES (1) ES465295A1 (fr)
FR (1) FR2374911A1 (fr)
GB (1) GB1551178A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2399845A2 (fr) * 1977-08-09 1979-03-09 Azuma Ichiro Adjuvant d'immunotherapie contenant un glycolipide comme ingredient actif et son procede de preparation
EP0031285A2 (fr) * 1979-12-21 1981-07-01 Pierre Fabre S.A. Préparations immunostimulantes à base d'ARN ribosomaux de Klebsiella pneumoniae et procédé de préparation de ces ARN
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
EP0714305B1 (fr) * 1993-08-27 2001-12-19 Vetrepharm, Inc. Composition et procede servant a stimuler les capacites de reproduction

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2399845A2 (fr) * 1977-08-09 1979-03-09 Azuma Ichiro Adjuvant d'immunotherapie contenant un glycolipide comme ingredient actif et son procede de preparation
EP0031285A2 (fr) * 1979-12-21 1981-07-01 Pierre Fabre S.A. Préparations immunostimulantes à base d'ARN ribosomaux de Klebsiella pneumoniae et procédé de préparation de ces ARN
EP0031285A3 (en) * 1979-12-21 1981-07-15 Pierre Fabre S.A. Immuno-stimulating preparations based on ribosomal rna and process for the preparation of the rna
WO1984000688A1 (fr) * 1979-12-21 1984-03-01 D Hinterland Lucien Dussourd Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
EP0035429B1 (fr) * 1980-02-20 1985-06-12 Pierre Fabre S.A. Complexe vaccinal contenant un antigène spécifique et vaccin le contenant

Also Published As

Publication number Publication date
FR2374911B1 (fr) 1979-04-13
DE2756851A1 (de) 1978-06-22
GB1551178A (en) 1979-08-22
BE861782A (fr) 1978-06-12
ES465295A1 (es) 1978-09-16

Similar Documents

Publication Publication Date Title
GR920100471A (el) Κα?αρισμένη ανοσογλοβουλίνη.
DE69409962T2 (de) Immuntoleranzinduzierendes agens
GEPI20105119B (en) Chimeric anti-cd20 antibody
CA2079881A1 (fr) Sequences nucleotidiques codant pour des regions variables de chaines .beta. des recepteurs des lymphocytes t humains, segments peptidiques correspondants et les applications diagnostiques et therapeutiques
BG102408A (en) The application of epinastine for the treatment of pains
DE3861707D1 (de) Mos-transistoren fuer hohe spannungen.
FR2679914B1 (fr) Composition de caoutchouc de la serie des dienes connjuguees.
GR78459B (fr)
BG102781A (en) Isolated dimer fibroblastactivation protein alpha and its application
SE9303827D0 (sv) Synkroniseringsanordning i en fordonsväxellåda
BG101892A (en) Sugar-modified cytostatics
BG102818A (en) D-manitol and method for its preparation
MX9603110A (es) Forma cristalina biodisponible de cefuroxima axetil.
TW326470B (en) Water dispersion of emulsion-graftpolymer used as binders of textile and leather
FR2374911A1 (fr) Adjuvants d'immunite non specifique
SG48816A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
IN181947B (fr)
PL288597A1 (en) Method of obtaining a pharmaceutic
CA2064029A1 (fr) Utilisation de mycobacterium vaccae dans la prevention du sida
WO1993023021A3 (fr) Combinaisons therapeutiques
DK0717744T3 (da) Fremgangsmåde til fremstilling af 9-(-2-hydroxy)-ethoxymethylguanin
MX9706744A (es) Proceso novedosos para preparar derivados de 2,3-dihidro-benzofuranol.
EP0601318A3 (fr) Procédé de préparation de conjugués d'un membre spécifique d'une réaction et d'une proteine glycosylée.
AU2629792A (en) Process for the purification of streptolysin 0, intact streptolysin 0 obtained by this process and its use
ES2052702T3 (es) Composiciones y metodo para el tratamiento de ulceras pepticas.

Legal Events

Date Code Title Description
TP Transmission of property
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0395, 920604

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0395, 761221

CL Concession to grant licences